Saniona AB (Nasdaq First North: SANION)

https://www.saniona.com

Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. The company has a significant portfolio of potential drug candidates at pre-clinical and clinical stage. The research is focused on ion channels, which makes up a unique protein class that enables and controls the passage of charged ions across cell membranes. Saniona has ongoing collaboration agreements with Upsher-Smith Laboratories, Inc., Productos Medix, S.A de S.V and Saniona's Boston based spinout Ataxion Inc., which is financed by Atlas Venture Inc. and Biogen Inc. Saniona is based in Copenhagen, Denmark, where it has a research center of high international standard. Saniona is listed at Nasdaq First North Premier and has about 4,400 shareholders. Pareto Securities is Certified Advisor for Saniona. The company's share is traded under the ticker SANION. *

	Start	2011-01-01 established
	Industry	CNS drug (neurological drug)
	Person	Drejer, Jørgen (Aniona ApS 201111– CEO before NeuroSearch)
	Person 2	Feldthus, Thomas (Saniona 201705 CFO before Symphogen –201103 CFO + Co-founder LEFT 3/12)

	Region	Ballerup
	Country	Denmark
	Street	154 Baltorpvej
	City	2750 Ballerup
	Tel	+45-70705225
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2014-11-11)

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Saniona AB (Nasdaq First North: SANION)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)